QDEL logo

QDEL
Quidelortho Corp

3,571
Mkt Cap
$808.75M
Volume
1.28M
52W High
$35.58
52W Low
$9.92
PE Ratio
-0.67
QDEL Fundamentals
Price
$11.86
Prev Close
$12.39
Open
$12.40
50D MA
$13.74
Beta
1.43
Avg. Volume
2.79M
EPS (Annual)
-$16.69
P/B
0.44
Rev/Employee
$419,538.46
$4,650.64
Loading...
Loading...
News
all
press releases
When Blood Compatibility Becomes a Pregnancy Risk
When Blood Compatibility Becomes a Pregnancy Risk When Blood Compatibility Becomes a Pregnancy Risk PR Newswire SAN DIEGO, May 21, 2026 SAN DIEGO, May 21, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader of in vitro diagnostics, has released episode 58 of its Science...
News Placeholder
More News
News Placeholder
QuidelOrtho to Participate in Upcoming June 2026 Investor Conferences
QuidelOrtho to Participate in Upcoming June 2026 Investor Conferences QuidelOrtho to Participate in Upcoming June 2026 Investor Conferences PR Newswire SAN DIEGO, May 20, 2026 SAN DIEGO, May 20, 2026 /PRNewswire/ --QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global...
News Placeholder
Citigroup Has Lowered Expectations for QuidelOrtho (NASDAQ:QDEL) Stock Price
Citigroup decreased their target price on shares of QuidelOrtho from $30.00 to $13.00 and set a "neutral" rating for the company in a research note on Wednesday...
News Placeholder
QDEL Stock Down as Q1 Earnings Miss Estimates, Revenues Down Y/Y
QuidelOrtho posts a wider Q1 loss as revenues fell 10.5% year over year, with weakness in respiratory testing pressuring margins and cash flow.
News Placeholder
QuidelOrtho (NASDAQ:QDEL) Hits New 12-Month Low After Earnings Miss
QuidelOrtho (NASDAQ:QDEL) Hits New 52-Week Low Following Weak Earnings...
News Placeholder
QuidelOrtho Q1 Earnings Call Highlights
QuidelOrtho (NASDAQ:QDEL) said its first-quarter 2026 results were pressured by a meaningfully weaker respiratory season, distributor caution in China ahead of expected national IVD pricing guidelines, and some order delays tied to Middle East disruptions, while management reiterated expectations fo...
News Placeholder
QuidelOrtho (NASDAQ:QDEL) Issues Earnings Results, Misses Expectations By $0.41 EPS
QuidelOrtho (NASDAQ:QDEL - Get Free Report) released its earnings results on Tuesday. The company reported ($0.04) earnings per share for the quarter, missing the consensus estimate of $0.37 by ($0.41). QuidelOrtho had a negative net margin of 41.46% and a positive return on equity of 5.91...
News Placeholder
QuidelOrtho (QDEL) Reports Q1 Loss, Tops Revenue Estimates
QuidelOrtho (QDEL) delivered earnings and revenue surprises of -110.81% and +0.28%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
News Placeholder
QuidelOrtho (NASDAQ:QDEL) Issues FY 2026 Earnings Guidance
QuidelOrtho (NASDAQ:QDEL) updated its FY 2026 earnings guidance. The company provided EPS guidance of 1.800-2.000 for the period, compared to the consensus estimate of 2.170. The company also issued...
News Placeholder
QuidelOrtho Reports First Quarter 2026 Financial Results
QuidelOrtho Reports First Quarter 2026 Financial Results QuidelOrtho Reports First Quarter 2026 Financial Results PR Newswire SAN DIEGO, May 5, 2026 LEX Diagnostics Acquisition Expected to Accelerate...
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available